The InPen System was designed to provide the benefits of insulin pump therapy to patients who cannot or will not use an insulin pump, including a dose calculator, dose reminders, and display of active insulin. The InPen System is designed for U-100 Humalog® or Novolog® insulin.
InPen automatically tracks insulin therapy, reports last dose and active insulin, and helps people with diabetes calculate mealtime and correction doses. This eases the burden of memorizing doses and improves the reliability of the insulin logbook.
Only about one third of people who take insulin are able to calculate a simple meal dose (meaning one with no insulin on board) and nearly 60 percent of insulin doses are taken with some insulin on board.1-3 The use of an automated dose calculator is associated with a 0.7 to 1.0 percent reduction in A1c. 4-8
As the health care provider, you determine the carbohydrate factor, correction factor, duration of insulin action, and target blood glucose at therapy start. The human factors studies we’ve conducted indicate that patients are able to easily enter these variables into the InPen system and use them to successfully calculate dosages.
The dose calculator automatically captures insulin on board and factors it into calculations. This helps to eliminate insulin stacking which can lead to hypoglycemia. InPen automatically differentiates between prime and therapy doses so the insulin on board calculation is always accurate.
In addition to the dose calculator, the InPen system includes optional dose reminders, reminders to check blood glucose after dosing, and temperature and age alerts for insulin. These alerts and reminders make it easier for your patient to better adhere to their insulin therapy.
Better clarity for Healthcare Providers, so you won’t need to rely solely on patient memory or reporting.
With insulin data on the smartphone, reports are intuitive and straightforward and give you a clear picture of how your patient has been managing their therapy. For charting you can generate a PDF that can be emailed right from your patient’s phone. Follow-ups are actionable and productive with complete data to inform your patient’s care.
The InPen Smart Insulin Delivery System will be available in 2017.
Visit the Get InPen page for more information.
- STUDY 1
- 1) Zaugg, Stephanie D., et al. “Diabetes numeracy and blood glucose control: association with type of diabetes and source of care.” Clinical diabetes: a publication of the American Diabetes Association 32.4 (2014): 152-157.
2) Cavanaugh, Kerri, et al. “Association of numeracy and diabetes control.” Annals of Internal Medicine 148.10 (2008): 737-746.
- STUDY 2
- 3) Walsh J, Wroblewski D, Bailey TS. Disparate Bolus Recommendations in Insulin Pump Therapy. AACE Annual Meeting, April 2007. Internet: http://www.diabetesnet.com/pdfs/AACE2007Poster.pdf
- STUDY 3
- 4) Delahanty LM, Halford BN. The role of diet behaviors in achieving improved glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care. 1993; 16(11):1453-1458.
5) Ziegler R, Cavan DA, Cranston I, et al. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial. Diabetes Care. 2013; 36(11):3613-3619.
6) Kaufman FR, Halvorson M, Carpenter S. Use of a plastic insulin dosage guide to correct blood glucose levels out of the target range and for carbohydrate counting in subjects with type 1 diabetes. Diabetes Care. 1999; 22(8):1252-1257.
7) Anderson DG. Multiple daily injections in young patients using the ezy-BICC bolus insulin calculation card, compared to mixed insulin and CSII. Pediatr Diabetes. 2009; 10(5):304-309.
8) Garg SK, Bookout TR, McFann KK, et al. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software. Diabetes Technol Ther. 2008; 10(5):369-375.